For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Sicor Inc.

USPTO Granted Patents = 26

% Expired Patents = 30.8

EPO Patents = 10

Trademarks = 4

Forward Citations = 28

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Nicola Diulgheroff (14 out of 14 patents)

Alessandro Pontiroli (14 out of 24 patents)

Judith Aronhime (9 out of 89 patents)

4. Jonathan Busolli (8 out of 8 patents)

5. Marco Villa (8 out of 35 patents)

6. Moran Pirkes (7 out of 7 patents)

7. Alexandr Jegorov (6 out of 28 patents)

8. Francesca Scarpitta (6 out of 8 patents)

9. Peter Lindsay MacDonald (5 out of 7 patents)

10. Csilla Nemethne Racz (4 out of 5 patents)

11. Pierluigi Rossetto (4 out of 6 patents)

12. Adrienne Kovacsne-Mezei (3 out of 15 patents)

13. Ales Gavenda (3 out of 10 patents)

14. Roberta Volonte (3 out of 3 patents)

15. Ettore Bigatti (3 out of 3 patents)

26 patents: Sort by Forward Citations

1. 9718829 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2017-08-01),

2. 9562050 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2017-02-07),

3. 9156841 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2015-10-13),

4. 9108962 - Forms of tiotropium bromide and processes for preparation thereof (2015-08-18),

5. 8846926 - Forms of tiotropium bromide and processes for preparation thereof (2014-09-30),

6. 8629152 - Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid (2014-01-14),

7. 8378103 - Process for the preparation of tiotropium bromide (2013-02-19),

8. 8362245 - Processes for preparing intermediates of pemetrexed (2013-01-29),

9. 8344143 - Process for the preparation of tiotropium bromide (2013-01-01),

10. 8217061 - Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereof (2012-07-10),

11. 8163913 - Forms of tiotropium bromide and processes for preparation thereof (2012-04-24),

12. 8088919 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2012-01-03),

13. 8067421 - Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α (2011-11-29),

14. 7994180 - Processes for preparing intermediates of pemetrexed (2011-08-09),

15. 7977348 - Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α (2011-07-12),

Sicor Inc. is a leading global pharmaceutical company specializing in the development, manufacturing, and distribution of injectable pharmaceutical products. With state-of-the-art facilities and a dedicated team of experts, we strive to provide high-quality and affordable medications to meet the needs of patients worldwide. Visit our website to learn more about our innovative product portfolio and commitment to healthcare excellence.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

26 Patents

#129 in Irvine, CA

#3,037 in California

#12,832 in US

#24,724 in the World

Irvine, CA, United States of America

Sicor Inc.

Forward Citations = 28

35 inventors:

Nicola Diulgheroff (14 out of 14 patents)

Alessandro Pontiroli (14 out of 24 patents)

Judith Aronhime (9 out of 89 patents)

4. Jonathan Busolli (8 out of 8 patents)

5. Marco Villa (8 out of 35 patents)

Please report any incorrect information to [email protected]

Loading…